Tonix Pharmaceuticals
TNXP
$0.17
Share price
5.31%
Change (1 day)
-63.37%
Change (1 year)
Categories
Tonix Pharmaceuticals (TNXP) - Cash on Hand
Cash on Hand as of September 2023 : $6.91 M
According to Tonix Pharmaceuticals's latest financial reports the company has $6.91 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Tonix Pharmaceuticals - Cash on Hand chart (from 2008 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.12 B | -32.71% |
| 2021-12-31 | $0.17 B | 131.82% |
| 2020-12-31 | $77.06 M | 585.11% |
| 2019-12-31 | $11.24 M | -55.07% |
| 2018-12-31 | $25.03 M | -1.81% |
| 2017-12-31 | $25.49 M | -2.39% |
| 2016-12-31 | $26.12 M | -39.28% |
| 2015-12-31 | $43.01 M | 12.65% |
| 2014-12-31 | $38.18 M | 365.54% |
| 2013-12-31 | $8.2 M | 359.5% |
| 2012-12-31 | $1.78 M | 4240.64% |
| 2011-12-31 | $0.04 M | -37.08% |
| 2010-12-31 | $0.06 M | 401.57% |
| 2009-12-31 | $0.01 M | -71.27% |
| 2008-12-31 | $0.04 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Aerie Pharmaceuticals AERI | $0.17 B | 2,394.42% | 🇺🇸 USA |
 Eagle Pharmaceuticals
EGRX | $15.35 M | 122.07% | 🇺🇸 USA |